RxDoctor Payments Data

Perrin Royea, PA

Physician Assistant · Pleasanton, CANPI 1285092908

Payments from drug & device makers

$7,226in general payments, 2019–2025

Across 411 payments — averaging $17.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$999
  • Johnson & Johnson$990
  • Takeda Pharmaceuticals U.S.A., Inc.$389
  • Madrigal Pharmaceuticals$372
  • Ardelyx, Inc.$248
  • plus $2K from 21 others

What the payments were for

  • Food & beverage$7,04898%
  • Education$1782%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,226 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$70,963
Medicare patients
401
Services billed
534

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide62$64,294
IbsrelaTenapanor Hcl13$60,849
CreonLipase/Protease/Amylase17$42,138
Dexlansoprazole DrDexlansoprazole50$21,712
TrulancePlecanatide20$16,100
MotegrityPrucalopride Succinate11$12,247
Pantoprazole Sodium850$11,859
Sucralfate491$10,016
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates131$8,347
Mesalamine24$7,783
ClenpiqSod Picosulf/Mag Ox/Citric Ac45$7,702
Omeprazole413$6,897
Dicyclomine Hcl313$6,613
Budesonide EcBudesonide11$5,981
Colesevelam Hcl22$5,975

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Creon$2,653$106,43279 claims
Ardelyx, Inc.Ibsrela$248$60,84913 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance, Plenvu$999$19,54643 claims
Takeda Pharmaceuticals U.S.A., Inc.Motegrity$389$12,24711 claims
Ferring Pharmaceuticals Inc.Clenpiq$69$7,70245 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Pleasanton

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →